Carmichael is a successful entrepreneur-investor with experience building companies and commercializing university based technology in partnership with Fortune 500 companies.
In 2016, Carmichael founded Material Impact Fund, which seeks out novel materials and grows them into great products and enduring companies that solve real-world problems. Material Impact’s investments include Soft Robotics, Zero Mass Water and Amastan Technologies.
As a General Partner at North Bridge Venture Partners, Carmichael financed and built several successful companies that create innovative products by applying material science, including 1366 technologies, Foro Energy, and MC10. Prior to North Bridge, Carmichael co-founded several ventures and the non-profit Diagnostics For All, and served as President and CEO of Arsenal Medical.
Carmichael received his BS and PhD in organic chemistry from Duke University and completed his postdoctoral National Science Foundation fellowship at Harvard University. Carmichael also has an MBA from MIT Sloan School of Management.